Showing 801 - 820 results of 974 for search '"Derby"', query time: 0.09s Refine Results
  1. 801

    SEROLOGICAL CHARACTERISTICS AND ANTIMOCROBIAL RESISTANCE OF SALMONELLA ISOLATES, RECOVERED FROM ANIMAL RAW MATERIAL by S. Ye. Shmaykhel, N. B. Shadrova, Ye. S. Yerofeyeva, S. I. Danilchenko

    Published 2019-12-01
    “…Among Salmonella group B, S. derby (4.4%) and S. typhimurium (2.2%) were more common; group C – S. infantis (29.0%), S. virchow (17.8%); group D – S. enteritidis (40.0%). …”
    Get full text
    Article
  2. 802

    Characterization of feline-originated probiotics Lactobacillus rhamnosus CACC612 and Bifidobacterium animalis subsp. lactis CACC789 and evaluation of their host response by Hyun-Jun Jang, Jung-Ae Kim, Yangseon Kim

    Published 2024-04-01
    “…Subsequently, they exhibited inhibitory effects against a broad spectrum of pathogenic bacteria, including E. coli (KCTC 2617), Salmonella Derby (NCCP 12,238), Salmonella Enteritidis (NCCP 14,546), Salmonella Typhimurium (NCCP 10,328), Clostridium difficile JCM 1296T. …”
    Get full text
    Article
  3. 803
  4. 804
  5. 805
  6. 806
  7. 807
  8. 808

    Gene Cloning and Expression of the Pyrroline-5-carboxylate Reductase Gene of Perennial Ryegrass (Lolium perenne) by Cao Li, Wei Shuqiang, Han Lei, Qian Yongqiang, Zhang Huali, Xin Haibo, Sun Zhenyuan

    Published 2015-09-01
    “…In the present study, the Lolium perenne L. pyrroline-5-carboxylate reductase (LpP5CR) gene was cloned from leaves of the cultivar ‘Derby’ using the RACE technique. The full-length LpP5CR gene was 1 047 bp in length, which comprised an open reading frame (ORF) of 840 bp in size. …”
    Get full text
    Article
  9. 809

    Overview of the development of quinolone resistance in Salmonella species in China, 2005–2016 by Song Q, Xu Z, Gao H, Zhang D

    Published 2018-02-01
    “…CIP resistance was found in nine of 51 serotypes: Derby, London, Kentucky, Indiana, Corvallis, Rissen, Hadar, Typhimurium, and Agona. …”
    Get full text
    Article
  10. 810
  11. 811

    Proteome-Based Serotyping of the Food-Borne Pathogens <i>Salmonella Enterica</i> by Label-Free Mass Spectrometry by Xixi Wang, Chen Chen, Yang Yang, Lian Wang, Ming Li, Peng Zhang, Shi Deng, Shufang Liang

    Published 2022-07-01
    “…Here, we applied a mass spectrum-based proteomic profiling for identifying five epidemiologically important <i>Salmonella enterica subsp. enterica</i> serovars (<i>Enteritidis</i>, <i>Typhimurium</i>, <i>London</i>, <i>Rissen</i> and <i>Derby</i>) in China. By label-free analysis, the 53 most variable serovar-related peptides, which were almost all enzymes related to nucleoside phosphate and energy metabolism, were screened as potential peptide biomarkers, and based on which a C5.0 predicted model for <i>Salmonella enterica</i> serotyping with four predictor peptides was generated with the accuracy of 94.12%. …”
    Get full text
    Article
  12. 812
  13. 813

    Serotyping and Antimicrobial Resistance Profiling of Multidrug-Resistant Non-Typhoidal <i>Salmonella</i> from Farm Animals in Hunan, China by Zhuohui Zhang, Jiyun Li, Rushun Zhou, Qianqian Xu, Shiyin Qu, Hongguang Lin, Yan Wang, Pishun Li, Xiaofeng Zheng

    Published 2023-07-01
    “…<i>S. typhimurium</i> (monophasic) 4,[5],12:i:- was the most common serotype, followed by <i>S. typhimurium</i> and <i>S. derby.</i> Most antimicrobial-resistant strains were isolated from pigs, indicating that they could be important reservoirs of resistant non-typhoidal <i>Salmonella</i> strains. …”
    Get full text
    Article
  14. 814
  15. 815

    Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies by Panos GD, Lakshmanan A, Dadoukis P, Ripa M, Motta L, Amoaku WM

    Published 2023-09-01
    “…Georgios D Panos,1,2 Arun Lakshmanan,1 Panagiotis Dadoukis,3 Matteo Ripa,4 Lorenzo Motta,4 Winfried M Amoaku1,2 1Department of Ophthalmology, Queen’s Medical Centre, Nottingham University Hospitals, Nottingham, UK; 2Division of Ophthalmology and Visual Sciences, Faculty of Medicine & Health Sciences, School of Medicine, University of Nottingham, Nottingham, UK; 3Eye Treatment Centre, Whipps Cross University Hospital, Barts Health NHS Trust, London, UK; 4Department of Ophthalmology, William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust, Kent, UKCorrespondence: Georgios D Panos, Department of Ophthalmology, Queen’s Medical Centre, Derby Road, Lenton, Nottingham, NG7 2UH, UK, Tel +44 115 924 9924, Email gdpanos@gmail.com Lorenzo Motta, Department of Ophthalmology, William Harvey Hospital, Kennington Road, Willesborough, Ashford, Kent, TN24 0LZ, UK, Tel +44 1233 633331, Email lorenzo.motta@nhs.netAbstract: Degenerative eye conditions such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion are major contributors to significant vision loss in developed nations. …”
    Get full text
    Article
  16. 816

    GIS Mapping of Short-Term Noisy Event of Diwali Night in Lucknow City by Rakesh Dubey, Shruti Bharadwaj, Md Iltaf Zafar, Vanshu Mahajan, Anubhava Srivastava, Susham Biswas

    Published 2021-12-01
    “…Short-term noise-sensitive events like New Year’s Eve, derby matches, DJ night, Diwali night (celebration with firecracker) in India, etc. create lots of noise in a short period. …”
    Get full text
    Article
  17. 817
  18. 818
  19. 819

    Methodological Appraisal of Phase 3 Clinical Trials in Geographic Atrophy by Marc Biarnés, Xavier Garrell-Salat, Alba Gómez-Benlloch, Mercè Guarro, Gabriel Londoño, Elena López, Sergi Ruiz, Meritxell Vázquez, Laura Sararols

    Published 2023-05-01
    “…Five phase 3 clinical trials have reported results, either partially or completely: GATHER1, DERBY/OAKS, CHROMA/SPECTRI, SEATTLE and GATE. Although there are many similarities between these trials in terms of endpoints or broad eligibility criteria, they differ in several aspects (metric of the primary endpoint, sample size, type of adverse events, etc.) that can influence the results, which are discussed. …”
    Get full text
    Article
  20. 820